Τρίτη 31 Οκτωβρίου 2017

[Correspondence] Neoadjuvant chemotherapy in oesophageal adenocarcinoma – Authors' reply

In response to the comments about the UK MRC OE05 trial,1 we acknowledge the ongoing debate about the treatment of patients with oesophageal adenocarcinoma.

http://ift.tt/2z1iwld

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου